Chemotherapy Usually Intended for Dogs is Treating a Red Fox’s Lymphoma

Purdue Veterinary Hospital and Wolf Park Collaborate to Treat an Unusual Patient

Chris sits beside Joker the fox holding out his hand as Joker stands on a log looking up at him
The most rewarding part of Joker’s treatment, for Dr. Chris Fulkerson, has been seeing his tumors responding and watching him live his life as normal. (Purdue University photo/John Underwood)

The Purdue University Veterinary Hospital works with many patients across species. None are more unusual perhaps than Joker, an eight-year-old silver-phased red fox undergoing treatment for lymphoma. Joker resides at Wolf Park, a nonprofit conservation facility located in nearby Battle Ground, Ind.

During a routine medical check in November, his handler, Kimber Hendrix, noticed small tumors on his tongue.  Wolf Park’s veterinarian, Dr. Julia Becker, sent a biopsy to the Animal Disease Diagnostic Laboratory at the Purdue University College of Veterinary Medicine, where Joker was diagnosed with T-cell lymphoma by Dr. Mario Sola, assistant professor of diagnostic pathology.  Dr. Becker then referred Joker’s case to Dr. Christopher Fulkerson, clinical assistant professor of veterinary medical oncology in the College of Veterinary Medicine. 

Dr. Fulkerson hadn’t previously worked with a fox patient. He and his team couldn’t find any literature about this type of lymphoma in foxes, so they are treating Joker based on a protocol often used for dogs with lymphoma. This chemotherapy protocol mainly uses chemotherapy pills, which the team thought was most likely to be well-tolerated and successful.

According to Dr. Fulkerson, Joker’s behavior is similar to that of a dog. He is as wild as possible at Wolf Park, but is social and trained for medical procedures. “He’s a really laid-back fox,” Hendrix said. “He’s a sweet guy to work with. He’s a great animal ambassador.”

Joker has been at Wolf Park since 2015, when he was rescued after being found under a porch. His laid back personality – accompanied with a knack of playing practical jokes on his den mate Scarlette – make him a favorite among visitors.

Chris wears a mask outside at Wolf Park as he holds out an egg that Joker the fox puts in his mouth
After a treatment at Wolf Park, Dr. Chris Fulkerson rewards Joker with his favorite treat: an egg. (Purdue University photo/John Underwood)

To minimize his stress and anxiety, as many procedures as possible are followed at Wolf Park. Since January, Dr. Fulkerson has been going to Wolf Park almost weekly to administer Joker’s treatment and check his laboratory reports. On these days, Joker is rewarded with a special treat: an egg.

Joker is responding well to chemotherapy. After a few weeks of treatment, his lymphoma is in partial remission, meaning most of the lesions have gone away or have substantially decreased in size. He is undergoing chemotherapy treatments until mid-April. The hope is that over time, complete remission is achieved with the disappearance of all lesions, although the treatment time frame may be extended if lesions remain.

“We follow his lab work really closely to make sure that the chemotherapy drugs aren’t having any adverse effects on his white blood cell count. This drug can also cause liver injury, so we monitor his liver function and liver values. That all has been good throughout all the treatment, with no signs of obvious chemotherapy side effects,” Dr. Fulkerson said.

In captivity, red foxes can live 12-14 years. Each day, Joker engages in training and enrichment with staff and volunteers, and he has plenty of energy to play with his enrichment objects. Hendrix said that even during treatment, he hasn’t had any bad days.

Dr. Fulkerson said that the most gratifying and exciting part of Joker’s treatment has been seeing his tumors responding and seeing him living his life as normal.

“I was wearing my mask because of COVID-19,” he said of a recent visit, “But I told his handlers if they could have seen my face under it, I probably had one of the biggest smiles I’d had in the last year just from seeing him frolicking around and being excited and happy.”

Dr. Fulkerson treats Joker the fox as his handler holds him on an exam table in the Purdue University Veterinary Hospital
Dr. Chris Fulkerson, clinical assistant professor of veterinary medical oncology, treats Joker, a silver-phased red fox, at the Purdue University Veterinary Hospital. (Purdue University photo/John Underwood)

Purdue has offset the cost of some of Joker’s procedures with teaching funds. Joker’s lymphoma already has been a good learning case for diagnostic imaging, oncology, and pathology.  Following Joker’s progress may help with treatment of similar cases in the future.

The remaining costs, as of now, have been fully funded through donations to Wolf Park, although more need may arise in the future if his treatment is extended.

Hendrix said she’s thankful that Wolf Park has been able to partner with Purdue on Joker’s treatment.

“I just really have loved the partnership that has blossomed between Wolf Park and Purdue throughout this,” she said. “I’d love for there to be something that comes out of this to help other exotics so that people learn more about the progression of the disease, can help other animals in human care and can do more for them. Anything that can be learned from his case would be wonderful.”

Dr. Fulkerson agrees. He and his team plan to compile a case report on Joker so that this treatment option is documented to help other foxes diagnosed with lymphoma in the future.

“One of the great things about being at Purdue and being an academic veterinarian is that we can see some of these unusual things, we have some resources we can bring to help us learn about them, and then we can share that information with other veterinarians to help other patients in the future,” he said.

Click here to view a full Purdue news release.

Writer(s): Kelsey Lefever, Purdue Marketing and Communications | pvmnews@purdue.edu

Recent Stories

“Paws Up” – brought to you by the PVM Wellness Committee

This week, we are proud to recognize Lorraine Fox, who is a business assistant with the Veterinary Medicine Procurement Center.

PVM Interview Days Move College Closer to Admitting the DVM Class of 2030

After a total of three afternoons dedicated to conducting in-person interviews with 226 prospective veterinary students, the Purdue University College of Veterinary Medicine is close to completing the process of admitting 84 members of the incoming first-year DVM class – the Class of 2030.  The students invited for the interview days were selected from a total pool of 1,930 applicants from across the country as well as countries abroad.

Experts to Gather at Purdue for Conference Addressing the Public Health Threat of Antimicrobial Resistance

The ongoing challenges posed by multi-drug resistant infections will be the focus of a multidisciplinary conference taking place in three weeks at Purdue University.  The Fourth Annual Conference on Antimicrobial Resistance is set for February 25–26, 2026 at Purdue’s Stewart Center in West Lafayette. Registration is still open for the event, which will bring together scientists and scholars from human and veterinary medicine, public health, research, and industry to address the determinants, dynamics and deterrence of drug resistance.

PVM’s Upcoming Coppoc One Health Lecture to Focus on Dogs as Sentinels of Environmental Exposure

The Purdue University College of Veterinary Medicine brings a leading One Health scholar to campus each year to address vital health issues from a One Health perspective as part of the Coppoc One Health Lecture series.  This year’s presentation, scheduled for February 26 in Lynn Hall Room 2026, is on the engaging topic, “One Health at Home: Dogs as Sentinels of Environmental Exposure.” The speaker will be Audrey Ruple, DVM, MS, PhD, DACVPM, MRCVS, the Dorothy A. and Richard G. Metcalf Professor of Veterinary Medical Informatics at the Virginia-Maryland College of Veterinary Medicine at Virginia Tech.

“Paws Up” – brought to you by the PVM Wellness Committee

Today we are happy to acknowledge our Student Success Center Team.

One Health: A ‘digital twin’ model for predicting cancer outcomes

The striking similarities between invasive bladder cancer in dogs and humans have fueled research advances for more than three decades. Most of that work has looked at separate aspects of the disease — risk factors, early detection, symptoms, treatment and gene expression. But a new project at Purdue University that combines many types of available data in a “digital twin” model of bladder cancer may prove powerful enough to predict patient outcomes, starting with the probability of metastasis.

Purdue Professor Emeritus Bill Blevins Wins Lifetime Achievement Award at ACVR Annual Meeting

The American College of Veterinary Radiology (ACVR) gave its esteemed Lifetime Achievement Award for 2024 to Purdue Professor Emeritus Bill Blevins, who is well known to countless Purdue Veterinary Medicine alumni for the expertise he taught them about all things Diagnostic Imaging during his long Purdue career.